Yew Bio Pharm Revenue, Profits - YEWB Annual Income Statement

Add to My Stocks
$0.3 $0 (0%) YEWB stock closing price Jul 19, 2018 (Closing)

Fundamental analysis of YEWB stock involves analyzing its financial statements, apart from checking the Yew Bio Pharm stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement for YEWB which shows a YOY revenue decline of -21.06% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the Yew Bio Pharm profit and loss statement for 2017 total to $1.73M. This line item shows that the operating expenses has increased compared with last year. Also check: Yew Bio Pharm assets and Yew Bio Pharm free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Yew Bio Pharm Revenues or Net Sales
40.53M51.34M29.57M7.72M7.43M6.72M5.96M
Cost Of Goods Sold (COGS)35.47M48.11M22.54M2.13M2.4M1.27M1.12M
Yew Bio Pharm Gross Profit
5.06M3.23M7.03M5.58M5.03M5.44M4.83M
Research & Development Expense-------
Selling General & Admin Expense1.73M1.11M1.89M1.3M1.13M3.24M-
Income Before Depreciation Depletion Amortization3.32M2.12M5.13M4.28M3.89M2.2M4.04M
Depreciation Depletion Amortization-------
Non Operating Income-0.11M-0.09M-----0.01M
Interest Expense-------
Yew Bio Pharm Pretax Income
3.21M2.02M5.3M4.28M3.89M2.2M4.04M
Provision for Income Taxes-------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations3.21M2M5.28M4.28M3.89M2.2M4.04M
Extraordinary Items & Discontinued Operations-------
Yew Bio Pharm Profit/ Loss (Net Income)
3.21M2M5.28M4.28M3.89M2.2M4.04M
Average Shares used to compute Diluted EPS53.94M51.88M52.11M----
Average Shares used to compute Basic EPS51.88M51.88M52.07M----
Income Before Nonrecurring Items3.21M2.01M5.29M----
Income from Nonrecurring Items-------
Yew Bio Pharm Earnings Per Share Basic Net
0.060.040.10----
Yew Bio Pharm Earnings Per Share Diluted Net
0.060.040.10----
EPS Diluted Before Nonrecurring Items0.060.040.10----
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Yew Bio Pharm stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that YEWB stock has a topline or revenue of $40.53M for 2017 as per this Yew Bio Pharm revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YEWB stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The YEWB financials along with Yew Bio Pharm historical stock prices provide a lot of details about the firm.

Yew Bio Pharm Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
5.66
PS Ratio (price sales ratio)
0.44
Operating Margin
6.9
Net Profit Margin
5
Dividend Yield
0%